Skip to main content

Advertisement

Log in

Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

A3 adenosine receptor has shown several physiological and pathological activities, including cell proliferation and apoptosis in various cancer cell lines. This study is designed to investigate molecular mechanism and apoptotic pathway of A3 adenosine receptor in DU-145, PC3 and LNcap-FGC10 human prostate cancer cells.

Methods

The expression level of A3 adenosine receptor was examined using real-time RT-PCR. cAMP concentration was also measured. MTT viability, cell counting and BrdU incorporation tests were used to study the cell proliferation effect of IB-MECA. Cell cycle analysis, Annexin V-FITC staining, Hoechst 33258 staining, mitochondrial membrane potential (ΔΨM), caspase-3 activity, Bcl-2 and Bax protein expression were used to detect apoptosis.

Result

A3 adenosine receptors mRNAs were detected at different levels. IB-MECA inhibited forskolin-stimulated cAMP. IB-MECA at (1 μM) suppressed cell proliferation and induced G1 cell cycle arrest. Indeed, IB-MECA down-regulated the expression of CDK4, cyclin D1 and up-regulated p53 expression. IB-MECA at (10–100 μM) induced apoptosis. The activity of caspase-3 was also increased. Expression of Bcl-2 was decreased in response to IB-MECA, while the expression of Bax protein was increased. The results showed a significant loss of ΔΨM, in a dose-dependent manner.

Conclusion

This study introduces a possible mechanism through A3 adenosine receptor activation. IB-MECA inhibited prostate cancer cells proliferation and induced G1 cell cycle arrest through p53, Cdk4/cyclinD1 pathway. Apoptosis determined by characteristic morphological changes and increased in sub-G1 population. Loss of MMP, activation of caspase-3 and down-regulation of Bcl-2 expression indicated mitochondrial signaling pathway that involved in the apoptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

References

  • Al-Mohanna MA, Al-Khodairy FM, Krezolek Z, Bertilsson PA, Al-Houssein KA, Aboussekhra A (2001) p53 is dispensable for UV-induced cell cycle arrest at late G(1) in mammalian cells. Carcinogenesis 22(4):573–578

    Article  PubMed  CAS  Google Scholar 

  • Anglin IE, Glassman DT, Kyprianou N (2002) Induction of prostate apoptosis by alpha1-adrenoceptor antagonists: mechanistic significance of the quinazoline component. Prostate Cancer Prostatic Dis 5(2):88–95. doi:10.1038/sj.pcan.4500561

    Article  PubMed  CAS  Google Scholar 

  • Appel E, Kazimirsky G, Ashkenazi E, Kim SG, Jacobson KA, Brodie C (2001) Roles of BCL-2 and caspase 3 in the adenosine A3 receptor-induced apoptosis. J Mol Neurosci 17(3):285–292. doi:10.1385/JMN:17:3:285

    Article  PubMed  CAS  Google Scholar 

  • Bracarda S, de Cobelli O, Greco C, Prayer-Galetti T, Valdagni R, Gatta G, de Braud F, Bartsch G (2005) Cancer of the prostate. Crit Rev Oncol Hematol 56(3):379–396. doi:10.1016/j.critrevonc.2005.03.010

    Article  PubMed  Google Scholar 

  • Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2(9):647–656. doi:10.1038/nrc883

    Article  PubMed  CAS  Google Scholar 

  • El-Darahali A, Fawcett H, Mader JS, Conrad DM, Hoskin DW (2005) Adenosine-induced apoptosis in EL-4 thymoma cells is caspase-independent and mediated through a non-classical adenosine receptor. Exp Mol Pathol 79(3):249–258. doi:10.1016/j.yexmp.2005.08.001

    Article  PubMed  CAS  Google Scholar 

  • Fishman P, Bar-Yehuda S, Ohana G, Pathak S, Wasserman L, Barer F, Multani AS (2000) Adenosine acts as an inhibitor of lymphoma cell growth: a major role for the A3 adenosine receptor. Eur J Cancer 36(11):1452–1458

    Article  PubMed  CAS  Google Scholar 

  • Fishman P, Bar-Yehuda S, Barer F, Madi L, Multani AS, Pathak S (2001) The A3 adenosine receptor as a new target for cancer therapy and chemoprotection. Exp Cell Res 269(2):230–236. doi:10.1006/excr.2001.5327

    Article  PubMed  CAS  Google Scholar 

  • Fishman P, Madi L, Bar-Yehuda S, Barer F, Del Valle L, Khalili K (2002) Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells. Oncogene 21(25):4060–4064. doi:10.1038/sj.onc.1205531

    Article  PubMed  CAS  Google Scholar 

  • Fishman P, Bar-Yehuda S, Ardon E, Rath-Wolfson L, Barrer F, Ochaion A, Madi L (2003) Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist. Anticancer Res 23(3A):2077–2083

    PubMed  CAS  Google Scholar 

  • Fishman P, Bar-Yehuda S, Ohana G, Barer F, Ochaion A, Erlanger A, Madi L (2004) An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B. Oncogene 23(14):2465–2471. doi:10.1038/sj.onc.1207355

    Article  PubMed  CAS  Google Scholar 

  • Fredholm BB, AP IJ, Jacobson KA, Klotz KN, Linden J (2001) International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53(4):527–552

    PubMed  CAS  Google Scholar 

  • Gao Z, Li BS, Day YJ, Linden J (2001) A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis. Mol Pharmacol 59(1):76–82

    PubMed  CAS  Google Scholar 

  • Ghavami S, Kerkhoff C, Los M, Hashemi M, Sorg C, Karami-Tehrani F (2004) Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. J Leukoc Biol 76(1):169–175. doi:10.1189/jlb.0903435

    Article  PubMed  CAS  Google Scholar 

  • Ghavami S, Kerkhoff C, Chazin WJ, Kadkhoda K, Xiao W, Zuse A, Hashemi M, Eshraghi M, Schulze-Osthoff K, Klonisch T, Los M (2008a) S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochim Biophys Acta 1783(2):297–311. doi:10.1016/j.bbamcr.2007.10.015

    Article  PubMed  CAS  Google Scholar 

  • Ghavami S, Rashedi I, Dattilo BM, Eshraghi M, Chazin WJ, Hashemi M, Wesselborg S, Kerkhoff C, Los M (2008b) S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J Leukoc Biol 83(6):1484–1492. doi:10.1189/jlb.0607397

    Article  PubMed  CAS  Google Scholar 

  • Ghavami S, Eshragi M, Ande SR, Chazin WJ, Klonisch T, Halayko AJ, McNeill KD, Hashemi M, Kerkhoff C, Los M (2010) S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3. Cell Res 20(3):314–331. doi:10.1038/cr.2009.129

    Article  PubMed  CAS  Google Scholar 

  • Hammond LA, Brown G, Keedwell RG, Durham J, Chandraratna RA (2002) The prospects of retinoids in the treatment of prostate cancer. Anticancer Drugs 13(8):781–790

    Article  PubMed  CAS  Google Scholar 

  • Hannon JP, Pfannkuche HJ, Fozard JR (1995) A role for mast cells in adenosine A3 receptor-mediated hypotension in the rat. Br J Pharmacol 115(6):945–952

    PubMed  CAS  Google Scholar 

  • Jacobson KA, Nikodijevic O, Shi D, Gallo-Rodriguez C, Olah ME, Stiles GL, Daly JW (1993) A role for central A3-adenosine receptors. Mediation of behavioral depressant effects. FEBS Lett 336(1):57–60

    Article  PubMed  CAS  Google Scholar 

  • Jajoo S, Mukherjea D, Watabe K, Ramkumar V (2009) Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity. Neoplasia 11(11):1132–1145

    PubMed  CAS  Google Scholar 

  • Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics. CA Cancer J Clin 60(5):277–300. doi:10.3322/caac.20073

    Article  PubMed  Google Scholar 

  • Jin S, Mazzacurati L, Zhu X, Tong T, Song Y, Shujuan S, Petrik KL, Rajasekaran B, Wu M, Zhan Q (2003) Gadd45a contributes to p53 stabilization in response to DNA damage. Oncogene 22(52):8536–8540. doi:10.1038/sj.onc.1206907

    Article  PubMed  CAS  Google Scholar 

  • Kang CM, Suh Y, Jang IS, Park SC (2001) Thymidine-dependent attenuation of the mitochondrial apoptotic pathway in adenosine-induced apoptosis of HL-60 cells. J Cancer Res Clin Oncol 127(9):570–576

    Article  PubMed  CAS  Google Scholar 

  • Kim SG, Ravi G, Hoffmann C, Jung YJ, Kim M, Chen A, Jacobson KA (2002) p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA. Biochem Pharmacol 63(5):871–880

    Article  PubMed  CAS  Google Scholar 

  • Kim SY, Kim JE, Lee KW, Lee HJ (2009) Lactococcus lactis ssp. lactis inhibits the proliferation of SNU-1 human stomach cancer cells through induction of G0/G1 cell cycle arrest and apoptosis via p53 and p21 expression. Ann N Y Acad Sci 1171:270–275. doi:10.1111/j.1749-6632.2009.04721.x

    Article  PubMed  Google Scholar 

  • Kohno Y, Sei Y, Koshiba M, Kim HO, Jacobson KA (1996) Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A(3) receptor agonists. Biochem Biophys Res Commun 219(3):904–910. doi:10.1006/bbrc.1996.0331

    Article  PubMed  CAS  Google Scholar 

  • Linden J (1994) Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci 15(8):298–306

    Article  PubMed  CAS  Google Scholar 

  • Lu J, Pierron A, Ravid K (2003) An adenosine analogue, IB-MECA, down-regulates estrogen receptor alpha and suppresses human breast cancer cell proliferation. Cancer Res 63(19):6413–6423

    PubMed  CAS  Google Scholar 

  • Madi L, Bar-Yehuda S, Barer F, Ardon E, Ochaion A, Fishman P (2003) A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition. J Biol Chem 278(43):42121–42130. doi:10.1074/jbc.M301243200

    Article  PubMed  CAS  Google Scholar 

  • Madi L, Ochaion A, Rath-Wolfson L, Bar-Yehuda S, Erlanger A, Ohana G, Harish A, Merimski O, Barer F, Fishman P (2004) The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition. Clin Cancer Res 10(13):4472–4479. doi:10.1158/1078-0432.CCR-03-0651

    Article  PubMed  CAS  Google Scholar 

  • Neary JT, McCarthy M, Kang Y, Zuniga S (1998) Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures. Neurosci Lett 242(3):159–162

    Article  PubMed  CAS  Google Scholar 

  • Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139(2):271–279

    Article  PubMed  CAS  Google Scholar 

  • Panjehpour M, Karami-Tehrani F (2004) An adenosine analog (IB-MECA) inhibits anchorage-dependent cell growth of various human breast cancer cell lines. Int J Biochem Cell Biol 36(8):1502–1509. doi:10.1016/j.biocel.2003.12.001

    Article  PubMed  CAS  Google Scholar 

  • Panjehpour M, Karami-Tehrani F (2007) Adenosine modulates cell growth in the human breast cancer cells via adenosine receptors. Oncol Res 16(12):575–585

    Article  PubMed  CAS  Google Scholar 

  • Poulsen SA, Quinn RJ (1998) Adenosine receptors: new opportunities for future drugs. Bioorg Med Chem 6(6):619–641

    Article  PubMed  CAS  Google Scholar 

  • Sai K, Yang D, Yamamoto H, Fujikawa H, Yamamoto S, Nagata T, Saito M, Yamamura T, Nishizaki T (2006) A(1) adenosine receptor signal and AMPK involving caspase-9/-3 activation are responsible for adenosine-induced RCR-1 astrocytoma cell death. Neurotoxicology 27(4):458–467. doi:10.1016/j.neuro.2005.12.008

    Article  PubMed  CAS  Google Scholar 

  • Saito M, Yaguchi T, Yasuda Y, Nakano T, Nishizaki T (2010) Adenosine suppresses CW2 human colonic cancer growth by inducing apoptosis via A(1) adenosine receptors. Cancer Lett 290(2):211–215. doi:10.1016/j.canlet.2009.09.011

    Article  PubMed  CAS  Google Scholar 

  • Salami S, Karami-Tehrani F (2003) Biochemical studies of apoptosis induced by tamoxifen in estrogen receptor positive and negative breast cancer cell lines. Clin Biochem 36(4):247–253

    Article  PubMed  CAS  Google Scholar 

  • Schorl C, Sedivy JM (2007) Analysis of cell cycle phases and progression in cultured mammalian cells. Methods 41(2):143–150. doi:10.1016/j.ymeth.2006.07.022

    Article  PubMed  CAS  Google Scholar 

  • Shieh DE, Chen YY, Yen MH, Chiang LC, Lin CC (2004) Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells. Life Sci 74(18):2279–2290. doi:10.1016/j.lfs.2003.09.060

    Article  PubMed  CAS  Google Scholar 

  • Tai CJ, Chang SJ, Chien LY, Leung PC, Tzeng CR (2005) Adenosine triphosphate induces activation of caspase-3 in apoptosis of human granulosa-luteal cells. Endocr J 52(3):327–335

    Article  PubMed  CAS  Google Scholar 

  • Von Lubitz DK, Lin RC, Popik P, Carter MF, Jacobson KA (1994) Adenosine A3 receptor stimulation and cerebral ischemia. Eur J Pharmacol 263(1–2):59–67

    Article  Google Scholar 

  • Wu LF, Li GP, Feng JL, Pu ZJ (2006) Molecular mechanisms of adenosine-induced apoptosis in human HepG2 cells. Acta Pharmacol Sin 27(4):477–484. doi:10.1111/j.1745-7254.2006.00302.x

    Article  PubMed  CAS  Google Scholar 

  • Yasuda Y, Saito M, Yamamura T, Yaguchi T, Nishizaki T (2009) Extracellular adenosine induces apoptosis in Caco-2 human colonic cancer cells by activating caspase-9/-3 via A(2a) adenosine receptors. J Gastroenterol 44(1):56–65. doi:10.1007/s00535-008-2273-7

    Article  PubMed  CAS  Google Scholar 

  • Zhang YX, Yu SB, Ou-Yang JP, Xia D, Wang M, Li JR (2005) Effect of protein kinase C alpha, caspase-3, and survivin on apoptosis of oral cancer cells induced by staurosporine. Acta Pharmacol Sin 26(11):1365–1372. doi:10.1111/j.1745-7254.2005.00205.x

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

Part of this work was supported by a PhD grant (Mahmoud Aghaei) from Tarbiat Modares University.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fatemeh Karami-Tehrani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aghaei, M., Panjehpour, M., Karami-Tehrani, F. et al. Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway. J Cancer Res Clin Oncol 137, 1511–1523 (2011). https://doi.org/10.1007/s00432-011-1031-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-011-1031-z

Keywords

Navigation